X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6017) 6017
Magazine Article (10) 10
Book Chapter (1) 1
Book Review (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
Transcript (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5661) 5661
male (3354) 3354
female (3349) 3349
dacarbazine - therapeutic use (2960) 2960
dacarbazine - analogs & derivatives (2892) 2892
oncology (2853) 2853
middle aged (2711) 2711
adult (2606) 2606
antineoplastic combined chemotherapy protocols - therapeutic use (2378) 2378
dacarbazine - administration & dosage (2262) 2262
aged (2114) 2114
temozolomide (1830) 1830
chemotherapy (1816) 1816
antineoplastic agents, alkylating - therapeutic use (1499) 1499
treatment outcome (1391) 1391
cancer (1277) 1277
brain neoplasms - drug therapy (1240) 1240
melanoma - drug therapy (1201) 1201
combined modality therapy (1152) 1152
dacarbazine (962) 962
radiotherapy (956) 956
glioblastoma (879) 879
doxorubicin - administration & dosage (856) 856
adolescent (854) 854
dacarbazine - adverse effects (846) 846
glioblastoma - drug therapy (829) 829
prognosis (797) 797
animals (764) 764
antineoplastic agents - therapeutic use (764) 764
hodgkin disease - drug therapy (764) 764
melanoma (757) 757
survival (703) 703
disease-free survival (697) 697
vincristine - administration & dosage (675) 675
clinical neurology (666) 666
antineoplastic combined chemotherapy protocols - adverse effects (658) 658
bleomycin - administration & dosage (648) 648
retrospective studies (613) 613
dacarbazine - pharmacology (600) 600
brain neoplasms - pathology (596) 596
cell line, tumor (590) 590
care and treatment (575) 575
medicine & public health (571) 571
neoplasm staging (566) 566
aged, 80 and over (562) 562
survival analysis (560) 560
tumors (546) 546
skin neoplasms - drug therapy (545) 545
vinblastine - administration & dosage (540) 540
survival rate (529) 529
glioblastoma multiforme (525) 525
gliomas (522) 522
therapy (518) 518
young adult (518) 518
brain neoplasms - therapy (515) 515
mice (512) 512
glioma - drug therapy (509) 509
melanoma - pathology (506) 506
antineoplastic combined chemotherapy protocols - administration & dosage (489) 489
follow-up studies (486) 486
doxorubicin - therapeutic use (429) 429
melanoma - secondary (428) 428
brain neoplasms - mortality (425) 425
trial (425) 425
brain neoplasms - radiotherapy (422) 422
glioblastoma - pathology (410) 410
malignant glioma (402) 402
glioma (399) 399
surgery (397) 397
procarbazine - administration & dosage (395) 395
metastatic melanoma (384) 384
phase-ii (384) 384
analysis (383) 383
drug administration schedule (376) 376
glioblastoma - therapy (372) 372
cyclophosphamide - administration & dosage (371) 371
prednisone - administration & dosage (368) 368
skin neoplasms - pathology (368) 368
neoplasm metastasis (364) 364
child (363) 363
research (357) 357
hodgkin disease - pathology (356) 356
melanoma - therapy (352) 352
apoptosis (350) 350
radiation-therapy (348) 348
disease progression (343) 343
immunotherapy (343) 343
antineoplastic agents (342) 342
magnetic resonance imaging (342) 342
glioblastoma - radiotherapy (341) 341
adjuvant temozolomide (339) 339
chemotherapy, adjuvant (338) 338
hematology (338) 338
vinblastine (333) 333
metastasis (332) 332
cisplatin - administration & dosage (329) 329
antineoplastic agents, alkylating - administration & dosage (328) 328
glioblastoma - mortality (316) 316
remission induction (316) 316
bleomycin - therapeutic use (313) 313
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5586) 5586
Japanese (129) 129
German (121) 121
French (116) 116
Russian (41) 41
Spanish (39) 39
Chinese (33) 33
Polish (29) 29
Italian (16) 16
Hungarian (14) 14
Bulgarian (6) 6
Hebrew (6) 6
Norwegian (5) 5
Czech (4) 4
Dutch (4) 4
Swedish (3) 3
Portuguese (2) 2
Serbian (2) 2
Finnish (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Paediatric drugs, ISSN 1174-5878, 2010, Volume 12, Issue 2, pp. 85 - 98
Hodgkin lymphoma is one of the few cancers that affect both adults and children. Cure rates for Hodgkin lymphoma remain among the best for pediatric cancers.... 
Anthracyclines, therapeutic use | Chlormethine, therapeutic use | Alkylating-agents, therapeutic use | Brentuximab-vedotin, therapeutic use | Cisplatin, therapeutic use | Bortezomib, therapeutic use | Bleomycin, therapeutic use | Children | Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2011, Volume 365, Issue 3, pp. 203 - 212
BEACOPP combination chemotherapy was compared with ABVD chemotherapy in advanced Hodgkin's disease. BEACOPP therapy was associated with higher initial rates of... 
CELL TRANSPLANT | MEDICINE, GENERAL & INTERNAL | VINORELBINE | MOPP | DISEASE | REGIMEN | IFOSFAMIDE | CHEMOTHERAPY | STANDARD | HYBRID | FERTILITY | Doxorubicin - therapeutic use | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - therapeutic use | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Young Adult | Hodgkin Disease - radiotherapy | Bleomycin - therapeutic use | Vinblastine - adverse effects | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Etoposide - adverse effects | Prednisone - adverse effects | Kaplan-Meier Estimate | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Etoposide - therapeutic use | Combined Modality Therapy | Bleomycin - adverse effects | Remission Induction | Disease-Free Survival | Procarbazine - adverse effects | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hodgkin Disease - therapy | Adolescent | Vincristine - therapeutic use | Vincristine - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Prednisone - therapeutic use | Procarbazine | Vinblastine | Disease | Etoposide | Prednisone | Family medical history | Radiation therapy | Patients | Lymphoma | Doxorubicin | Survival | Vincristine | Studies | Hepatitis | Dacarbazine | Cyclophosphamide | Chemotherapy | Bleomycin | Tomography | Lymphomas | Hodgkin's disease
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2014, Volume 127, Issue 10, pp. 931 - 932
Internal Medicine | MEDICINE, GENERAL & INTERNAL | STEVENS-JOHNSON-SYNDROME | Acetaminophen - adverse effects | Dacarbazine - adverse effects | Methylprednisolone - therapeutic use | Humans | Middle Aged | Dexamethasone - adverse effects | Male | Antineoplastic Agents - therapeutic use | Wound Healing | Anticonvulsants - adverse effects | Piracetam - therapeutic use | Stevens-Johnson Syndrome - therapy | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - administration & dosage | Antiemetics - adverse effects | Oxycodone - therapeutic use | Stevens-Johnson Syndrome - etiology | Anticonvulsants - therapeutic use | gamma-Globulins - therapeutic use | Analgesics, Opioid - therapeutic use | Stevens-Johnson Syndrome - diagnosis | Dexamethasone - therapeutic use | Glioblastoma - pathology | Piracetam - analogs & derivatives | Glioblastoma - complications | Glioblastoma - drug therapy | gamma-Globulins - administration & dosage | Dacarbazine - therapeutic use | Piracetam - adverse effects | Erythema - chemically induced | Analgesics, Opioid - adverse effects | Antineoplastic Agents - adverse effects | Antiemetics - therapeutic use | Erythema - diagnosis | Dacarbazine - analogs & derivatives | Oxycodone - adverse effects | Acetaminophen - therapeutic use | Proton Pump Inhibitors - adverse effects | Omeprazole - therapeutic use | Immunologic Factors - administration & dosage | Omeprazole - adverse effects | Proton Pump Inhibitors - therapeutic use | Piperidines - therapeutic use | Quinazolines - therapeutic use | Piperidines - adverse effects | Quinazolines - adverse effects | Drug Combinations | Immunologic Factors - therapeutic use | Methylprednisolone - administration & dosage | Medicine, Experimental | Toxic epidermal necrolysis | Medical research | Research
Journal Article
Cochrane library, ISSN 1465-1858, 2018, Volume 2018, Issue 11, p. CD008218
Background This is an updated version of the original Cochrane Review published in September 2014. The most common primary brain tumours in adults are gliomas.... 
Hypertension | Camptothecin | Neurological | Glioblastoma | Neoplasm Recurrence, Local | Neovascularization, Pathologic | Antineoplastic Agents | Angiogenesis Inhibitors | Bevacizumab | Brain Neoplasms | Randomized Controlled Trials as Topic | Primary brain tumours | Neuro‐oncology | Antibodies, Monoclonal, Humanized | Dacarbazine | Irinotecan | Neurology | Progression‐Free Survival | Lomustine | Snake Venoms | Temozolomide | Medicine General & Introductory Medical Sciences | Proteinuria | Cancer | MEDICINE, GENERAL & INTERNAL | STANDARD TREATMENT | RECURSIVE PARTITIONING ANALYSIS | NEWLY-DIAGNOSED GLIOBLASTOMA | RANDOMIZED PHASE-III | SINGLE-AGENT BEVACIZUMAB | BEVACIZUMAB PLUS IRINOTECAN | CENTRAL-NERVOUS-SYSTEM | OPEN-LABEL | QUALITY-OF-LIFE | ADJUVANT TEMOZOLOMIDE | Neovascularization, Pathologic - mortality | Bevacizumab - therapeutic use | Snake Venoms - therapeutic use | Dacarbazine - therapeutic use | Humans | Neoplasm Recurrence, Local - drug therapy | Antineoplastic Agents - therapeutic use | Brain Neoplasms - blood supply | Irinotecan - therapeutic use | Temozolomide - therapeutic use | Proteinuria - chemically induced | Hypertension - chemically induced | Dacarbazine - analogs & derivatives | Angiogenesis Inhibitors - therapeutic use | Lomustine - therapeutic use | Brain Neoplasms - mortality | Angiogenesis Inhibitors - adverse effects | Camptothecin - analogs & derivatives | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Camptothecin - therapeutic use | Brain Neoplasms - drug therapy | Neovascularization, Pathologic - drug therapy | Progression-Free Survival | Glioblastoma - drug therapy | Glioblastoma - blood supply | Glioblastoma - mortality
Journal Article
International journal of molecular sciences, ISSN 1422-0067, 2019, Volume 20, Issue 1, p. 170
Due to the rarity and heterogeneity of bone and soft-tissue sarcomas, investigation into molecular targets and new treatments has been particularly... 
Sarcoma | Chemotherapy | Immunotherapy | sarcoma | BIOCHEMISTRY & MOLECULAR BIOLOGY | NUCLEAR EXPORT | OPEN-LABEL | MODIFIED T-CELLS | chemotherapy | CHEMISTRY, MULTIDISCIPLINARY | AUTOLOGOUS TUMOR LYSATE | CYTOKINE RELEASE SYNDROME | PHASE-I TRIAL | immunotherapy | HIGH-GRADE OSTEOSARCOMA | MURAMYL TRIPEPTIDE | EUROPEAN-ORGANIZATION | ENDOTHELIAL GROWTH-FACTOR | Osteosarcoma - drug therapy | Sarcoma - immunology | Humans | Soft Tissue Neoplasms - drug therapy | Antineoplastic Agents - therapeutic use | Bone Neoplasms - pathology | Furans - therapeutic use | Soft Tissue Neoplasms - immunology | Trabectedin - therapeutic use | Ipilimumab - therapeutic use | Ketones - therapeutic use | Bone Neoplasms - drug therapy | Antibodies, Monoclonal, Humanized - therapeutic use | Immunotherapy, Adoptive | Drug Therapy | Nivolumab - therapeutic use | Bone Neoplasms - immunology | Sarcoma - drug therapy | Sarcoma - pathology | Sorafenib - therapeutic use | Osteosarcoma - immunology | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Progression-Free Survival | Soft Tissue Neoplasms - pathology | Osteosarcoma - pathology | Platelet-derived growth factor | Gemcitabine | Ifosfamide | Therapeutic applications | Clinical trials | Malignancy | Metastasis | Kinases | Survival | Doxorubicin | Patients | Anticancer properties | Soft tissues | Studies | Angiogenesis | Dacarbazine | Receptors | Antitumor agents | Vascular endothelial growth factor | Growth factors | Cancer | Tumors
Journal Article
Clinical cancer research, ISSN 1557-3265, 2010, Volume 16, Issue 8, pp. 2443 - 2449
Journal Article
Neuro-oncology (Charlottesville, Va.), ISSN 1522-8517, 11/2016, Volume 18, Issue 11, pp. 1529 - 1537
Journal Article
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 12/2015, Volume 314, Issue 23, pp. 2535 - 2543
Journal Article
Hematology, ISSN 1520-4391, 2016, Volume 2016, Issue 1, pp. 316 - 322
Treating Hodgkin lymphoma by using chemotherapy with or without radiotherapy is highly successful, with substantially fewer deaths from lymphoma than from... 
ABVD | INTERIM-PET | POSITRON-EMISSION-TOMOGRAPHY | INTERGROUP TRIAL | BREAST-CANCER RISK | INVOLVED-FIELD RADIOTHERAPY | INTERPRETATION CRITERIA | OPEN-LABEL | STAGE-III | HEMATOLOGY | INTERNATIONAL PROGNOSTIC SCORE | EDUCATION, SCIENTIFIC DISCIPLINES
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 3/2009, Volume 92, Issue 1, pp. 33 - 35
.... Its use poses higher risks of lymphopenia and opportunistic infections. Prophylaxis for Pneumocystis... 
Oncology | Opportunistic infections | Temozolomide | Medicine & Public Health | Lymphopenia | ONCOLOGY | RISK | RADIOTHERAPY | ANEMIA | PURE | RED-CELL APLASIA | CLINICAL NEUROLOGY | Dacarbazine - adverse effects | Red-Cell Aplasia, Pure - drug therapy | Heptanoic Acids - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Tuberculosis, Pulmonary - drug therapy | Tuberculosis, Pulmonary - chemically induced | Dacarbazine - analogs & derivatives | Anti-Inflammatory Agents - therapeutic use | Female | Isoniazid - therapeutic use | Rifampin - therapeutic use | Fluoxetine - therapeutic use | Pyrroles - therapeutic use | Anti-Ulcer Agents - therapeutic use | Omeprazole - therapeutic use | Anti-Infective Agents - therapeutic use | Anticonvulsants - therapeutic use | Combined Modality Therapy | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Brain Neoplasms - drug therapy | Radiotherapy | Pyrazinamide - therapeutic use | Atorvastatin Calcium | Cyclosporine - therapeutic use | Dexamethasone - therapeutic use | Phenobarbital - therapeutic use | Anticholesteremic Agents - therapeutic use | Antibiotics, Antitubercular - therapeutic use | Antineoplastic Agents, Alkylating - adverse effects | Glioblastoma - drug therapy | Prednisone - therapeutic use | Online health care information services | Pneumonia | Tuberculosis | Gliomas | Analysis | Bacterial pneumonia | Brain tumors | Pyrazinamide | Health aspects | Rifampin | Index Medicus
Journal Article
Fertility and Sterility, ISSN 0015-0282, 2014, Volume 102, Issue 3, pp. 667 - 674.e3
Objective To determine consequences of lymphoma treatments on sperm characteristics and sperm DNA, and to evaluate predictors of sperm recovery. Design... 
Internal Medicine | Obstetrics and Gynecology | sperm DNA | sperm chromatin | radiotherapy | spermatogenesis | Hodgkin | Lymphoma | chemotherapy | DNA INTEGRITY | FERTILITY PRESERVATION | CHROMATIN-STRUCTURE | TESTICULAR CANCER | CRYOPRESERVATION | SEMEN QUALITY | OBSTETRICS & GYNECOLOGY | REPRODUCTIVE BIOLOGY | HODGKINS-DISEASE | MEN | GONADAL DYSFUNCTION | Doxorubicin - therapeutic use | Sperm Count | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Mechlorethamine - adverse effects | Male | Vinblastine - therapeutic use | Cyclophosphamide - adverse effects | DNA - radiation effects | Mechlorethamine - therapeutic use | Case-Control Studies | Cyclophosphamide - therapeutic use | Young Adult | Bleomycin - therapeutic use | Vinblastine - adverse effects | Adult | DNA - drug effects | Spermatogenesis - radiation effects | Spermatogenesis - drug effects | Prednisone - adverse effects | Spermatozoa - radiation effects | Semen Analysis | Combined Modality Therapy | Bleomycin - adverse effects | Spermatozoa - drug effects | DNA - chemistry | Procarbazine - adverse effects | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, Non-Hodgkin - therapy | Hodgkin Disease - therapy | Vincristine - therapeutic use | Vincristine - adverse effects | Spermatozoa - physiology | DNA Damage | Longitudinal Studies | Doxorubicin - adverse effects | Prednisone - therapeutic use | Care and treatment | Spermatozoa | Lymphomas | Drug therapy | DNA | Cancer
Journal Article